Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 7
1990 7
1991 3
1992 9
1993 5
1994 8
1995 18
1996 18
1997 22
1998 15
1999 15
2000 12
2001 24
2002 15
2003 4
2004 7
2005 13
2006 12
2007 8
2008 8
2009 5
2010 5
2011 6
2012 9
2013 5
2014 4
2015 6
2016 7
2017 3
2018 4
2019 2
2020 5
2021 4
2022 4
2023 5
2024 2
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
A Double-Blind Randomised Clinical Trial of Terbinafine-Nanostructured Lipid Carriers: Should We Anticipate This Strategy for Effective Topical Treatment of Onychomycosis?
Parsay S, Saeedi M, Abastabar M, Hedayati MT, Rahimnia SM, Gholizadeh N, Kazeminejad A, Morteza-Semnani K, Gashti RZ, Asare-Addo K, Moazeni M, Nokhodchi A. Parsay S, et al. Mycoses. 2025 Jun;68(6):e70076. doi: 10.1111/myc.70076. Mycoses. 2025. PMID: 40525269 Free PMC article. Clinical Trial.
BACKGROUND: Oral terbinafine (TBF) is the drug of choice for onychomycosis management. To treat and heal the rough and thick nail tissue affected by fungal agents, a high dose and plasma concentration of this drug is necessary. ...OBJECTIVES: This study aimed to employ nan …
BACKGROUND: Oral terbinafine (TBF) is the drug of choice for onychomycosis management. To treat and heal the rough and thick nail tis …
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Wingfield AB, et al. Br J Dermatol. 2004 Jan;150(1):119-26. doi: 10.1111/j.1365-2133.2004.05643.x. Br J Dermatol. 2004. PMID: 14746625 Clinical Trial.
OBJECTIVES: The aim of this study was to compare the efficacy of itraconazole, terbinafine and fluconazole with that of griseofulvin after 4 weeks of therapy. METHODS: Patients aged 12-76 years with the clinical diagnosis of TI were randomly assigned to one of four treatme …
OBJECTIVES: The aim of this study was to compare the efficacy of itraconazole, terbinafine and fluconazole with that of griseofulvin …
Mupirocin vs terbinafine in impetigo.
Ciftci E, Guriz H, Aysev AD. Ciftci E, et al. Indian J Pediatr. 2002 Aug;69(8):679-82. doi: 10.1007/BF02722704. Indian J Pediatr. 2002. PMID: 12356219 Clinical Trial.

Twenty-five and 23 patients were treated with mupirocin and terbinafine, respectively. The clinical cure rates were 100% for the mupirocin group and 70% for the terbinafine group (p < 0.05). The bacteriological eradication rate for mupirocin-treated children was

…
Twenty-five and 23 patients were treated with mupirocin and terbinafine, respectively. The clinical cure rates were 100% for the mupi …
Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T, Tiihonen R, Soini M, Wangel M, Sipponen A, Jokinen JJ. Auvinen T, et al. Br J Dermatol. 2015 Oct;173(4):940-8. doi: 10.1111/bjd.13934. Epub 2015 Oct 1. Br J Dermatol. 2015. PMID: 26036329 Clinical Trial.

At 10 months, clinical responses were complete in four patients (16%) treated with terbinafine, and partial in seven (30%), seven (28%) and nine (36%) patients treated with resin, amorolfine and terbinafine, respectively (P < 0.05). Resin, amorolfine and terbi

…
At 10 months, clinical responses were complete in four patients (16%) treated with terbinafine, and partial in seven (30%), seven (28 …
Non-dermatophytes in onychomycosis of the toenails.
Ellis DH, Watson AB, Marley JE, Williams TG. Ellis DH, et al. Br J Dermatol. 1997 Apr;136(4):490-3. Br J Dermatol. 1997. PMID: 9155945 Clinical Trial.
A multicentre trial for the treatment of dermatophyte onychomycosis of the toenails with terbinafine was carried out in Australia and New Zealand. Between eight and 12 nail samples were obtained from each of the 118 patients in the 48-week trial, and each sample was invest …
A multicentre trial for the treatment of dermatophyte onychomycosis of the toenails with terbinafine was carried out in Australia and …
Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor.
Aste N, Pau M, Pinna AL, Colombo MD, Biggio P. Aste N, et al. Mycoses. 1991 Jul-Aug;34(7-8):353-7. doi: 10.1111/j.1439-0507.1991.tb00676.x. Mycoses. 1991. PMID: 1803242 Clinical Trial.
The antifungal efficacy and tolerability of 1% terbinafine cream vs. 1% bifonazole cream were assessed in a single blind randomized trial in patients with pityriasis versicolor. ...By the 2nd week of treatment, 2 terbinafine patients were mycologically cured (10%). …
The antifungal efficacy and tolerability of 1% terbinafine cream vs. 1% bifonazole cream were assessed in a single blind randomized t …
Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.
Schopf R, Hettler O, Bräutigam M, Weidinger G, Kaben U, Mayser P, Resl V. Schopf R, et al. Mycoses. 1999;42(5-6):415-20. doi: 10.1046/j.1439-0507.1999.00477.x. Mycoses. 1999. PMID: 10536434 Clinical Trial.
In this double-blind clinical trial 429 patients (217 terbinafine and 212 clotrimazole) were randomized to receive twice daily terbinafine 1% topical solution for 1 week followed by a vehicle application for 3 weeks, or 1% clotrimazole solution for 4 weeks. ...In th …
In this double-blind clinical trial 429 patients (217 terbinafine and 212 clotrimazole) were randomized to receive twice daily ter …
Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
Fuhr R, Cook D, Ridden J, Nield K, Leigh E, Cook J, Davies-Strickleton H, Dobmeyer J. Fuhr R, et al. Mycoses. 2022 Jun;65(6):661-669. doi: 10.1111/myc.13448. Epub 2022 May 20. Mycoses. 2022. PMID: 35466481 Clinical Trial.
BB2603 is a nano-formulation of the antifungal drug terbinafine with the polymer polyhexamethylene biguanide (PHMB) as an excipient to enhance solubility and drug delivery to skin and nails. ...The pharmacokinetic, safety and efficacy data from this trial support further d …
BB2603 is a nano-formulation of the antifungal drug terbinafine with the polymer polyhexamethylene biguanide (PHMB) as an excipient t …
Clinical efficacy and safety of oral terbinafine in fungal mycetoma.
N'diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R. N'diaye B, et al. Int J Dermatol. 2006 Feb;45(2):154-7. doi: 10.1111/j.1365-4632.2004.02392.x. Int J Dermatol. 2006. PMID: 16445509 Clinical Trial.
OBJECTIVES: An open-label study was performed to assess the efficacy and safety of terbinafine in the treatment of eumycetoma. METHODS: Single-center, open-label study, including 27 patients with signs and symptoms of eumycetoma which had developed within 5 years and was c …
OBJECTIVES: An open-label study was performed to assess the efficacy and safety of terbinafine in the treatment of eumycetoma. METHOD …
Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium.
Matsumoto T, Tanuma H, Kaneko S, Takasu H, Nishiyama S. Matsumoto T, et al. Mycoses. 1995 Mar-Apr;38(3-4):135-44. doi: 10.1111/j.1439-0507.1995.tb00037.x. Mycoses. 1995. PMID: 7477090 Clinical Trial.
A pharmacokinetic study revealed that terbinafine was detected in the nail tissue at and after week 2. It reached 0.78 ng mg-1 at the end of week 12 and remained at almost the same level thereafter. Terbinafine was also detected in hair at and after week 23. The ave …
A pharmacokinetic study revealed that terbinafine was detected in the nail tissue at and after week 2. It reached 0.78 ng mg-1 at the …
297 results